Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2020

Aug 14, 2020

SELL
$19.49 - $28.11 $166,483 - $240,115
-8,542 Closed
0 $0
Q1 2020

May 15, 2020

BUY
$16.13 - $30.17 $137,782 - $257,712
8,542 New
8,542 $208,000
Q4 2019

Feb 14, 2020

SELL
$20.78 - $29.99 $466,968 - $673,935
-22,472 Closed
0 $0
Q3 2019

Nov 14, 2019

BUY
$23.87 - $30.93 $536,406 - $695,058
22,472 New
22,472 $539,000

Others Institutions Holding VCYT

About VERACYTE, INC.


  • Ticker VCYT
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 71,575,904
  • Market Cap $2.57B
  • Description
  • Veracyte, Inc. operates as a diagnostics company worldwide. The company offers Afirma Genomic Sequencing Classifier and Xpression Atlas, which are used to determine patients with indeterminate results are benign to avoid unnecessary surgery; Decipher Prostate Biopsy and Radical Prostatectomy for prostate cancer diagnosis; Prosigna Breast Cancer ...
More about VCYT
Track This Portfolio

Track Paloma Partners Management CO Portfolio

Follow Paloma Partners Management CO and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Paloma Partners Management CO, based on Form 13F filings with the SEC.

News

Stay updated on Paloma Partners Management CO with notifications on news.